PA-18-055 |
Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PA-18-489 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PA-18-344 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PA-18-484 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PA-18-345 |
NIH Research Project Grant (Parent R01 Clinical Trial Required) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PA-18-058 |
Prescription Drug Abuse (R01 Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PAR-18-219 |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PAR-18-218 |
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Research program not yet identified. Learn about the research led by the NIH Institutes and Centers that are part of the initiative. |
no summary
|
RFA-HL-20-031 |
HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
PAR-20-092 |
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
RFA-DA-18-020 |
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Research program not yet identified. Learn about the research led by the NIH Institutes and Centers that are part of the initiative. |
no summary
|
RFA-DA-22-031 |
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
RFA-DA-22-032 |
HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
NOT-DA-21-066 |
Notice of Correction to RFA-DA-22-031, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
NOT-DA-21-067 |
Notice of Correction to RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|
RFA-HL-22-013 |
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed) |
Novel Therapeutic Options for Opioid Use Disorder and Overdose |
Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose |
no summary
|